Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TJ0113 200mg
DRUG
2 trials
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
, Hangzhou PhecdaMed Co., Ltd.
Conditions
Parkinson Disease
Parkinson Disease 6, Early-Onset
Parkinson's Disease (PD)
Phase 2
Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease
Completed
NCT06596005
Second Affiliated Hospital, School of Medicine, Zhejiang University
Parkinson Disease
Start: 2024-09-18
End: 2025-09-09
Updated: 2026-01-16
Phase 3
Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
Not yet recruiting
NCT07741045
Hangzhou PhecdaMed Co., Ltd.
Parkinson Disease 6, Early-Onset, Parkinson's Disease (PD)
Start: 2026-08-03
End: 2028-11-15
Target: 300
Updated: 2026-08-12
Related Papers
Preclinical safety and toxicokinetic evaluation of TJ0113, a first-in-class mitophagy inducer for Parkinson's disease.
2025-09-13